Clinical Evaluation of MyoCare in Europe (CEME): study protocol for a prospective, multicenter, randomized, double-blinded, and controlled clinical trial
Abstract Background Myopia prevalence has been increasing in the last decades, and its pathological consequences, including myopic maculopathy and high myopia-associated optic neuropathy, are now one of the most common causes of visual impairment. It is estimated that by 2050, more than 50% of Europ...
Main Authors: | Cristina Alvarez-Peregrina, Miguel Angel Sanchez-Tena, Clara Martinez-Perez, Cesar Villa-Collar, Clinical Evaluation of MyoCare in Europe –the CEME Study Group, Arne Ohlendorf |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07696-0 |
Similar Items
-
New Designs of Spectacle Lenses for the Control of Myopia Progression: A Scoping Review
by: Marta Lupon, et al.
Published: (2024-02-01) -
Updates on Optical Strategies of Myopia Control
by: Masoud Khorrami-Nejad, et al.
Published: (2022-10-01) -
Spectacle lenses with slightly aspherical lenslets for myopia control: clinical trial design and baseline data
by: Junhong Chen, et al.
Published: (2022-08-01) -
Spectacle measurements versus contact lens measurements of the angle of deviation in myopic patients with strabismus
by: Dina H Hassanein, et al.
Published: (2023-01-01) -
Effectiveness of peripheral defocus spectacle lenses in myopia control: a Meta-analysis and systematic review
by: Ji-Xian Ma, et al.
Published: (2022-10-01)